Conclusion: The less invasive surfactant administration effectively reduced the FiO2 requirement by more than 20% to 90.6%, potentially reducing the need for iMV within 72 hours after birth compared to the INSURE technique, reducing hospital stays, contributing to reduce treatment costs, improve outcomes of preterm infants.